Claims
- 1. An oligonucleotide which comprises:
a) a nucleotide sequence which hybridizes to an internal segment of a target nucleic acid downstream from a hybridization site for a primer such that extension of the primer displaces the oligonucleotide from the target sequence, and; b) a 3′ terminal nucleotide or a nucleotide about one to four nucleotides from the 3′ terminal nucleotide which is diagnostic for a single nucleotide polymorphism which may be present in the target nucleic acid.
- 2. The oligonucleotide of claim 1 wherein the diagnostic nucleotide is the 3′ terminal nucleotide (N) or N-1.
- 3. The oligonucleotide of claim 1 further comprising a nondiagnostic nucleotide within about one to fifteen nucleotides from the diagnostic nucleotide.
- 4. The oligonucleotide of claim 3 wherein the nondiagnostic nucleotide is within about one to five nucleotides from the diagnostic nucleotide.
- 5. The oligonucleotide of claim 4 wherein the diagnostic and nondiagnostic nucleotides, respectively, are selected from the group consisting of N and N-3, N-1 and N-2, and N-2 and N-3.
- 6. The oligonucleotide of claim 1 which hybridizes downstream from an amplification primer for the target nucleic acid.
- 7. An oligonucleotide which is an amplification primer for an isothermal nucleic acid amplification reaction, the oligonucleotide comprising:
a) a 3′ terminal nucleotide which is complementary to the target, and; b) about one to four nucleotides from the 3′ terminal nucleotide, a diagnostic nucleotide for a single nucleotide polymorphism which may be present in a target to be amplified.
- 8. The oligonucleotide of claim 7 wherein the diagnostic nucleotide is at N-1 or N-2.
Parent Case Info
[0001] This application is a division of pending prior application Ser. No. 09/335,218, filed Jun. 17, 1999.
Divisions (1)
|
Number |
Date |
Country |
Parent |
09335218 |
Jun 1999 |
US |
Child |
09778175 |
Feb 2001 |
US |